EUVIMEDEUVIMED entdecken
Crossref

Brain 18F-FDG-PET abnormalities and their associations with neuropsychological assessment in initially hospitalized patients with post-COVID-19 conditions: a prospective and longitudinal study

Sébastien Heyer iD, Mylène Meyer, Gabriela Hossu, Matthieu Doyen, Alexandra Bruyère, François Goehringer, Louise Tyvaert, Lucie Hopes, Antoine Verger

European Journal of Nuclear Medicine and Molecular Imaging · 2025

DOI: 10.1007/s00259-025-07204-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Sébastien Heyer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, Allée du Morvan, Nancy, 54000, France. s.heyer@c…. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron-Emission Tomography, COVID-19, Neuropsychological Tests. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RATIONALE: This study aims to longitudinally investigate the associations between brain 18F-FDG-PET metabolism and neuropsychological assessment (NPA) in initially hospitalized patients with post-COVID-19 conditions (PCCs). METHODS: Patients with PCC and confirmed neurological impairment were prospectively included and underwent both brain 18F-FDG-PET and NPA at inclusion and one year later. Brain18F-FDG-PET metabolism was correlated with NPA tests. The identified hypometabolic clusters after quantitative voxel-by-voxel group analyses were correlated with the NPA results. RESULTS: Twenty-three patients (51.0 ± 9.5 years; 9 women) were included. Brain 18F-FDG-PET metabolism was correlated with the results of the Hamilton Anxiety Rating Scale (HARS), episodic memory, executive function and autonomy tests (p-voxel < 0.005; p-cluster < 0.05 uncorrected). Two cerebellar hypometabolic clusters were found in patients with PCC at inclusion and one year later (n = 16, p-voxel < 0.005; p-cluster < 0.05 corrected). Cerebellar metabolism was associated with an abnormal HARS test at one year (p ≤ 0.04) but not at inclusion. At one year, no brain metabolic recovery and no significant improvement in NPA tests were observed. CONCLUSION: Brain 18F-FDG-PET metabolism is associated with the results of neuropsychological tests in initially hospitalized patients with PCC, especially the metabolism of the cerebellum, which was found to be decreased in patients, and symptoms of anxiety experienced by patients. Similarly, brain 18F-FDG-PET hypometabolism and impairment in NPA tests did not significantly improve one year later.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Positron-Emission TomographyCOVID-19Neuropsychological TestsBrainHospitalizationHumansFemaleMaleMiddle AgedLongitudinal StudiesProspective StudiesAdultRadiopharmaceuticals

Stichwörter der Autor:innen

COVID-19FDGLongitudinalNeuropsychological assessmentPET

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, Allée du Morvan, Nancy, 54000, France. s.heyer@chru-nancy.fr.
  • Department of Neurology, University Hospital, Nancy, 54000, France.
  • Université de Lorraine, IADI, INSERM U1254, Nancy, F-54000, France.
  • CIC, Innovation Technologique, Université de Lorraine, University Hospital Center of Nancy, Nancy, France.
  • Department of Infectious Diseases, CHRU Nancy, Nancy, 54000, France.
  • Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, Allée du Morvan, Nancy, 54000, France.

ORCID-Profile: Sébastien Heyer

Zitieren

APA

Heyer, S., Meyer, M., Hossu, G., Doyen, M., Bruyère, A., Goehringer, F., Tyvaert, L., Hopes, L., & Verger, A. (2025). Brain 18F-FDG-PET abnormalities and their associations with neuropsychological assessment in initially hospitalized patients with post-COVID-19 conditions: a prospective and longitudinal study. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07204-3

Vancouver

Heyer S, Meyer M, Hossu G, Doyen M, Bruyère A, Goehringer F, et al. Brain 18F-FDG-PET abnormalities and their associations with neuropsychological assessment in initially hospitalized patients with post-COVID-19 conditions: a prospective and longitudinal study. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-025-07204-3

BibTeX
@article{Heyer2025,
  author = {Heyer, Sébastien and Meyer, Mylène and Hossu, Gabriela and Doyen, Matthieu and Bruyère, Alexandra and Goehringer, François and Tyvaert, Louise and Hopes, Lucie and Verger, Antoine},
  title = {Brain 18F-FDG-PET abnormalities and their associations with neuropsychological assessment in initially hospitalized patients with post-COVID-19 conditions: a prospective and longitudinal study},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  doi = {10.1007/s00259-025-07204-3}
}
Kostenlos starten →